RAPT Therapeutics Inc. (RAPT)
undefined
undefined%
At close: undefined
0.93
2.00%
After-hours Dec 13, 2024, 07:42 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue - 1.53M 3.81M 5.04M - - -
Cost of Revenue 3.55M 2.81M 996.00K - 1.33M 1.24M 1.38M
Gross Profit -3.55M -1.28M 2.82M 5.04M -1.33M -1.24M -1.38M
Operating Income -127.06M -85.80M -69.21M -53.21M -43.63M -36.95M -29.33M
Interest Income - - - - - - -
Pretax Income -116.80M -83.84M -69.20M -51.90M -42.34M -36.15M -29.11M
Net Income -116.80M -81.88M -68.21M -52.89M -43.00M -36.15M -29.11M
Selling & General & Admin 26.06M 20.24M 16.04M 12.77M 8.72M 5.18M 3.71M
Research & Development 101.00M 67.08M 56.98M 45.48M 34.91M 31.77M 25.62M
Other Expenses - 1.96M 5.00K 1.31M 1.29M 800.00K 216.00K
Operating Expenses 127.06M 87.32M 73.02M 58.26M 43.63M 36.95M 29.33M
Interest Expense - - - - - - -
Selling & Marketing Expenses - - - - - - -
Cost & Expenses 127.06M 87.32M 73.02M 58.26M 43.63M 36.95M 29.33M
Income Tax - -1.96M -996.00K 990.00K 660.00K 800.00K -
Shares Outstanding (Basic) 38.34M 32.54M 27.39M 24.13M 21.83M 17.33M 14.46M
Shares Outstanding (Diluted) 38.34M 32.54M 27.39M 24.13M 21.83M 17.33M 14.46M
EPS (Basic) -3.05 -2.52 -2.49 -2.19 -1.97 -2.09 -2.01
EPS (Diluted) -3.05 -2.52 -2.49 -2.19 -1.97 -2.09 -2.01
EBITDA -125.85M -84.75M -68.21M -52.09M -42.30M -35.71M -27.95M
Depreciation & Amortization 1.22M 2.81M 996.00K 1.12M 1.33M 1.24M 1.38M